1117
Round the World
From our
Correspondents
United States
DISHONEST STUDENTS
THE
intensity
ofcompetition
togain
entrance to a medical school has often been commented on and concern has been felt at unethical conduct beforeentrance-cheating, stealing
notes, andsabotaging
other students’
experiments. Having
beenaccepted,
thereis,
inmost cases, the hurdle of the examinations of the National Board of Medical Examiners. At this
level,
the students of the medical schools in the US arejoined by
those from overseas or offshore medicalschools,
andimmigrants hoping
topractise, lucratively,
inthe States.
Only
with these hurdlespassed, including
the Flexexamination for
foreign
medicalgraduates,
cangraduates hope
toreap the
golden
harvest unlessthey
present false credentials. Theextent of fraud is now so
widespread
that the credentials of hundreds ofphysicians
arebeing closely
scrutinised.Recently
it has become clear that fraud andcheating
in examinations is common at everylevel,
since papers have beenstolen, copied,
andsold,
sometimes athigh prices.
Examination after examination has beencompromised
in this way. The medical
college aptitude
test,widely
used as anentry
criterion,
was found last year to have been available to many examinees beforethey
sat the paperwhile,
at the sametime,
theexamination for doctors trained overseas was so
badly compromised
that a quarter of those
sitting
it hadprior knowledge
of thequestions.
Person or persons unknown stole a copy, sold it for$50 000,
thepurchaser
madecopies
available at$10 000 toothers,
who made further
copies
and sold them at$5 000apiece.
Suchpractices
have increased in the past few years. Some individuals have beencaught trying
to bribepeople
to obtaincopies
of theexaminations but the
investigations
made so far have not identifiedthe
original thieves, though inquiries
arebeing actively pursued
inseveral states, one country overseas, and one area of the Caribbean.
When
illegally-acquired copies
of examinations may bebought
inthe streets,
something
drastic must be done. Thesepractices question
the whole examination system and theeasily
memorisedmultiple-choice questions
inparticular.
DrCooper,
of the Association of American MedicalColleges,
believes that differenttests
might
be used,including
essay-typequestions.
Here hepoints, perhaps,
to thekey
issue. How far should medical schools takeresponsibility
forinsuring
that theirgraduates
are ofacceptable
calibre? For years, many have taken the attitude that a student who is
good enough
to beaccepted
isautomatically
entitled tograduate.
Few if any
colleges
have finalexaminations,
clinicalexaminations,
or even monitor standards
by using
externalexaminers,
and many appear indifferent to the standards achieved. If students can pass the NationalBoards,
well andgood,
butif they
cannot,they
may still be awarded an MD. It seemslikely
that without achange
in attitudes within medicalcolleges
the situation willpersist
or get worse.In the past the medical
profession
hasenjoyed high public
esteemand
enjoyed
a rich financial status. But if there are not a fewphysicians
withfrankly
fraudulent credentials and ahigh proportion suspected of cheating
their way tolicensure,
thenpublic opinion
may be less favourable.West
Germany
BITTER PILLS—A WASTED OPPORTUNITY?
SINCE
January
a book called BitterePillenl (bitter pills)
has headedthe best-seller list in West
Germany, having
drawn an enthusiastic welcome from commentators inmagazines
and ontelevision,
andapparently
also a substantial section ofsociety.
The GermanMedical
Association,
thepharmaceutical industry,
and theprofessional journals
take a very differentview,
and have attacked itfiercely.
Such a medical "war" has not been seen since 1976 when1 Langbein K, Martin H-P, Sichrovsky P, Weiss H. Bittere Pillen. Nutzen und Risiken der Arzneimittel. Ein kritischer Ratgeber Cologne: Kiepenheuer and Witsch,
1983
Hackenthal launched his book on
malpractice
insurgery.
2The book-offered in gorgeous blue
covers-provides
information on more than 2000
drugs
that account for about 80% ofWest
Germany
and Austria’spharmaceutical
market.Along
withshort accounts of clinical symptoms,
body
systems, anddiseases,
itprovides
a somewhatunsystematic description
of the unwanted and wanted effects ofdrugs
in each of 75 areas ofapplication.
Theemphasis
is very much on the unwantedeffects,
and the information isqualitative
rather thanquantitative.
The few references arealmost
exclusively
tosecondary publications-notably,
asingle
textbook of
pharmacology3 and
the"transparenz-telegram" (a
critical
guide
for doctors and consumerspublished by
aprivate drug
information agency in West
Berlin).
Inclearly’laid
out tables thebook offers
simple
valuejudgments
on eachdrug including
classification under the
headings "general useful",
"usefulonly
inlimited
conditions", "barely useful",
and "not useful butdangerous" (in
which case the reader is advised not to takeit).
Additional tables carry information
(some
of it never intended for thepublic eye)
on the economics of eachdrug including
worth ofbusiness and number of
packages
sold in1981,
on the costs of asingle package
in the chemist’sshop,
on differentformulations,
andon whether it is
prescription-only
or over-the-counter. The Austrian authors-twojournalists,
asociologist,
and a chemist whowas
formerly
sales manager in a West Germanpharmaceutical company-have
written aprevious best-seller,
GesundeGeschdfte,4
4which revealed
shady practices
in thepharmaceutical industry
andpublished
confidential letters betweencompanies
and doctors(mainly academics).
What should we make of this
enterprise?
For the doctorsbeing pilloried
it is difficult to take a detachedview,
but the information does seem deficient in many ways. Diseasepresentation
andseverity
are not
discussed;
incidence and extent ofdrug
effects(whether
beneficial or
adverse)
are notspecified;
and statements tend to be based not on clinical trials but on(sometimes obsolete)
reports ofexperimental pharmacology-a
direct anddangerous
consequence of WestGermany’s
attitude to controlledstudies.S
Economic dataare accurate, but the reader is in no
position
toweigh
costsagainst
benefits when the other information is soimpressionistic.
Forexample,
all antihistamines are dismissed asweakly
andunreliably effective,
therefore seldomuseful;
so the advice is not to take them inany kind of
allergic
reaction. Thisjudgment
is based onfaulty
citation of the
pharmacological textbook neglect
of the verdict of thetransparenz-telegram,
andcomplete
failure to noticerecently published
trials onallergic rhinitisb
andanaphylactoid reactions.°8 Why
is this book a best-seller? Notonly patients
but also doctorsare
deluged
withmisleading
news about the benefits and risks ofdrugs,
and there isundoubtedly
a need for terse,simple
information. The firm pronouncements of Bittere Pillen may be
wrong-sometimes
evendangerously
so-butthey
fill this need.Lastly,
the man-in-the-streetregards drugs
with considerableemotion,
and the text is wellgeared
to this. It addresses anxieties about multinationalcompanies,
attacks theirprofits,
and blames theindustry
forcausing
excessivedrug consumption (and
the doctors forcomplicity).
Butwhy
was this book not writtenby
any of us in the medicalprofession?
Department of Theoretical Surgery, University of Marburg (Lahn),
Federal Republic of Germany W. LORENZ
2. Hackenthal J. Auf Messers Schneide. Kunst und Fehler der Chirurgen. Hamburg.
Rowohlt, 1976
3. Forth W, Henschler D, Rummel W. Allgemeine und spezielle Pharmakologie und Toxikologie. Für Studenten. Mannheim, Wien, Zurich Bibliographisches Institut, 1980.
4. Langbein K, Martin H-P, Weiss H, Werner R (pseudonymous for Sichrowsky P).
Gesunde Geschäfte. Die Praktiken der Pharma-Industrie Cologne Kiepenheuer and Witsch, 1981
5. Lorenz W. Attitudes to controlled clinical trials Lancet 1982; ii: 1460-61.
6. Mygind N. Mediators of nasal allergy J Allerg Clin Immunol 1982; 70: 149-59.
7. Lorenz W, Doenicke A, Schöning B, Mamorski J, Weber D, Hinterlang E, Schwarz B, Neugebauer. E. H1 + H2-receptor antagonists for premedication in anaesthesia and surgery: a critical view based on randomized clinical trials with Haemaccel® and various antiallergic drugs. Agents Actions 1980; 10: 114-24.
8. Schöning B, Lorenz W, Doenicke A Prophylaxis of anaphylactoid reactions to a polypeptidal plasma substitute by H1-plus H2-receptor antagonists: Synopsis of three randomized controlled trials Klin Wschr 1982; 60: 1048-55